Asia Pacific Products In Later Stages Of Development Compared To Other Markets
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Late-stage development of innovative drugs has grown rapidly in Asia Pacific in recent years, but early-phase development continues to lag in the region as global companies face the limitations of development budgets